By G HossainPosted on January 23, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Corxel will use the fundraising proceeds to advance the oral GLP-1 therapy CX11 through mid-stage development in the U.S., as well as prepare for its Phase III studies. China’s Corxel Nabs $287M Series D1 to Bankroll GLP-1 Pill Post navigation Moderna Won’t Run Phase III Vaccine Trials as Skepticism Grows in US: BloombergTennessee CPAs lobby lawmakers